News
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...
Agomab Therapeutics NV (?Agomab') today announced that interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor ...
The NIMML Institute, ("NIMML"), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for inflammatory and autoimmune diseases, will present results from two novel ...
Single-game tickets are on sale now! Explore all of the exciting matchups and incredible promotions below. Promotions are subject to change or cancellation. Looking to create unforgettable memories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results